Nanexa AB (publ) is a firm dedicated to developing advanced drug delivery solutions through nanotechnology. The company leverages its proprietary PharmaShell platform, a nanobased system that utilizes atomic layer deposition (ALD) technology for drug administration. Furthermore, Nanexa is progressing NEX-18, a PharmaShell-based candidate specifically designed to address severe conditions such as Myelodysplastic Syndrome and Acute Myeloid Leukemia. The company was established in 2007 and is headquartered in Uppsala, Sweden.
Show more...
FAQ
Nanexa AB 的股票代號是什麼?▼
根據交易所不同,股票代號可能會有所差異。例如,在 Stockholm Exchange 交易所,Nanexa AB 的股票以代號 NANEXA-BTA.ST 進行交易。
Nanexa AB 去年的營收是多少?▼
Nanexa AB 去年的營收為 36.15MSEK。
Nanexa AB 去年的淨利是多少?▼
NANEXA-BTA.ST 去年的淨收益為 -11.39MSEK。
Nanexa AB 有多少名員工?▼
截至 August 23, 2026,公司共有 16 名員工。
Nanexa AB 位於哪個產業?▼
Nanexa AB從事於Health & Wellness產業。
Nanexa AB 何時完成拆股?▼
Nanexa AB 最近沒有進行任何拆股。
Nanexa AB 的總部在哪裡?▼
Nanexa AB 的總部位於 瑞典 的 Uppsala。